1. Market Research
  2. > Healthcare Market Trends
  3. > Healthcare Analysis & Statistics in Japan, November 2019

Healthcare Analysis & Statistics in Japan, November 2019

1-30 of about 2700 reports

World Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

World Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and Instrumentation

  • $ 19500
  • Industry report
  • September 2019

World Transfusion Diagnostics Market for 40 Immunohematology and NAT Assays: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Latest Technologies and InstrumentationThe ...

  • Industries : Pathology
  • Countries : Europe, United States, Japan, World
Global Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Global Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 19500
  • Industry report
  • September 2019

Global Hemostasis Diagnostic Analyzers and Reagent Market for over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewSummaryThis ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics
  • Countries : United States, World, Japan, Europe
Global Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Global Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 19500
  • Industry report
  • August 2019

Global Infectious Disease Testing Market for Over 100 Tests: Emerging Opportunities in the US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation ...

  • Industries : Pathology
  • Countries : Japan, World, United States, Europe
Competing in the Global Cancer Diagnostics Market: Supplier Shares, Segment Forecasts for Major Tumor Markers, Growth Opportunities

Competing in the Global Cancer Diagnostics Market: Supplier Shares, Segment Forecasts for Major Tumor Markers, Growth Opportunities

  • $ 18500
  • Industry report
  • November 2019

Competing in the Global Cancer Diagnostics Market: Supplier Shares, Segment Forecasts for Major Tumor Markers, Growth OpportunitiesThis new LeadingMarketResearch.com comprehensive seven-country study identifies ...

  • Industries : Diagnostics
  • Countries : World, Japan
Transfusion Diagnostics Market: Immunohematology and NAT Testing--US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging Opportunities

Transfusion Diagnostics Market: Immunohematology and NAT Testing--US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, Emerging Opportunities

  • $ 18500
  • Industry report
  • November 2019

Transfusion Diagnostics Market: Immunohematology and NAT Testing--US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review, ...

  • Industries : Diagnostics
  • Countries : United States, Europe, Japan
Global Automated Microbiology Market for over 100 Tests

Global Automated Microbiology Market for over 100 Tests

  • $ 18500
  • Industry report
  • September 2019

Global Automated Microbiology Market for over 100 Tests: US, Europe, JapanLeadingMarketResearch.com's new report is a seven-country strategic analysis of the major business opportunities emerging ...

  • Industries : Pathology
  • Countries : World, United States, Japan
Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 18500
  • Industry report
  • September 2019

Global Virology and Bacteriology Market for over 100 Tests: US, Europe, Japan--Supplier Shares and Strategies, Test Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewThis new report ...

  • Industries : Pathology
  • Countries : Japan, World, United States, Europe
Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing

  • $ 14500
  • Industry report
  • October 2019

Global Nucleic Acid Testing/NAT Market, 2019-2023: Emerging Opportunities in US, Europe, Japan--Supplier Shares and Strategies, Country Volume and Sales Segment Forecasts--Infectious and Genetic Diseases, ...

  • Industries : Diagnostics
  • Countries : Japan, United States, World, Europe
Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities

Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, Instrumentation Review, Opportunities

  • $ 14500
  • Industry report
  • October 2019

Global Molecular Diagnostic Analyzers and Reagent Forecasts for 100 Tests: USA, Europe, Japan--Infectious and Genetic Diseases, Cancer, Forensic and Paternity Testing--Supplier Shares, Emerging Technologies, ...

  • Industries : Diagnostics
  • Countries : Japan, United States, World, Europe
Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation Review

  • $ 14500
  • Industry report
  • August 2019

Coagulation Testing Analyzers and Reagents Market for Over 40 Tests: US, Europe, Japan--Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Technology and Instrumentation ReviewSummaryThis ...

  • Industries : Diagnostics, In Vitro Diagnostics, In Vitro Diagnostics
  • Countries : United States, Japan, Europe, World
Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation Review

  • $ 12500
  • Industry report
  • November 2019

Global Infectious Disease Molecular Diagnostics Forecasts for 100 Tests: US, Europe, Japan--Supplier Shares, Competitive Strategies, Volume and Sales Segment Forecasts, Innovative Technologies, Instrumentation ...

  • Industries : Diagnostics
  • Countries : World, United States, Europe, Japan
Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • October 2019

Axial Spondyloarthritis: Global Drug Forecast and Market Analysis to 2028SummaryAxial spondyloarthritis (axSpA) is a disease group encompassing both ankylosing spondylitis (AS) and non-radiographic axial ...

  • Industries : Medical Biotechnology, Pharmaceutical, Therapy, Biopharmaceutical, Biopharmaceutical
  • Countries : United States, Japan, World
Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • September 2019

Ovarian Cancer: Opportunity Analysis and Forecasts to 2028SummaryThe latest report “Ovarian Cancer: Opportunity Analysis and Forecasts to 2028” values the Ovarian Cancer market at $1.8bn in 2018 across ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : United States, World, Japan
Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • August 2019

Hemophilia A and B - Global Drug Forecast and Market Analysis to 2028SummaryHemophilia A and B are rare, genetic, X-linked deficiencies in the blood clotting factors VIII (FVIII) and IX (FIX), respectively.Patients ...

  • Industries : Pathology, Healthcare
  • Countries : United States, World, China, East Asia, North America, Japan
Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028

  • $ 10995
  • Industry report
  • August 2019

Prostate Cancer: Global Drug Forecast and Market Analysis to 2028SummaryThe prostate cancer market will undergo a moderate increase at a compound annual growth rate (CAGR) of 3.3% from an estimated $9.3bn ...

  • Industries : Cancer, Therapy, Pathology
  • Countries : United States, East Asia, Japan, China, World, North America
Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028

Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028

  • $ 10995
  • Industry report
  • August 2019

Allergic Rhinitis Immunotherapy: Opportunity Analysis and Forecasts to 2028SummaryAllergic rhinitis (AR) is a common, IgE-mediated inflammatory disease in which an individual reacts to an otherwise innocuous ...

  • Industries : Medical Biotechnology, Biopharmaceutical, Biopharmaceutical, Pharmaceutical, Chronic Disease, Pathology
  • Countries : United States, Japan, World, East Asia, North America
Cyramza

Cyramza

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCyramza (ramucirumab; Eli Lilly) is a fully human vascular endothelial growth factor receptor (VEGFR)-2-directed immunoglobulin G1 monoclonal antibody that binds to the extracellular domain ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Nexavar

Nexavar

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewNexavar (sorafenib; Bayer/Amgen) is an orally available, multi-targeted tyrosine kinase inhibitor that is directed against several targets, including CRAF, BRAF, RET, KIT, FMS-like tyrosine ...

  • Industries : Pathology, Cancer, Therapy
  • Countries : United States, Japan, European Union
Opdivo

Opdivo

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewOpdivo (nivolumab; Bristol-Myers Squibb/Ono Pharmaceutical) is a fully human immunoglobulin G4 PD-1 immune checkpoint inhibitor that binds to the checkpoint receptor PD-1 expressed on activated ...

  • Industries : Cancer, Pathology
  • Countries : United States, European Union, Japan
Lenvima

Lenvima

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewLenvima (lenvatinib; Eisai/Merck and Co) is an orally available small molecule inhibitor of multiple tyrosine kinases, including vascular endothelial growth factor receptor (VEGFR), platelet-derived ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Keytruda

Keytruda

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewKeytruda (pembrolizumab; Merck and Co) is a humanized monoclonal antibody designed to inhibit the PD-1 co-inhibitory receptor. The interaction between PD-1 and its primary ligand, PD-L1, inhibits ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan, European Union
Stivarga

Stivarga

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewStivarga (regorafenib; Bayer/Amgen) is an orally available small molecule inhibitor that is currently approved for the treatment of previously treated hepatocellular carcinoma patients. It ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Cabometyx

Cabometyx

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewCabometyx (cabozantinib; Exelixis/Ipsen/Takeda) is an orally available small molecule inhibitor which has been shown to suppress tumor growth and metastasis by inhibiting the activity of multiple ...

  • Industries : Pathology, Cancer
  • Countries : United States, Japan, European Union
Imfinzi

Imfinzi

  • $ 10000
  • Industry report
  • September 2019

Drug OverviewImfinzi (durvalumab; AstraZeneca) is a human monoclonal antibody directed against programmed death-ligand 1 (PD-L1). The interaction between PD-L1 and its receptor, programmed death-1 (PD-1), ...

  • Industries : Pathology, Cancer
  • Countries : European Union, Japan, United States
Global Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

Global Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, Yersinia

  • $ 5500
  • Industry report
  • October 2019

Global Enteric Diseases: Campylobacter, Cryptosporidium, E. Coli, Enterovirus, Rhinovirus, Rotavirus, Salmonella, Shigella, Vibrio, YersiniaAbout this ReportThis new 389-page report presents detailed analysis ...

  • Industries : Diagnostics, Medical Biotechnology, Pathology
  • Countries : World, United States, Europe, Japan
Global Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Country Shares, Market Segment Forecasts, Competitive Strategies, Technology and Instrumentation Review, Opportunities for Suppliers

Global Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Country Shares, Market Segment Forecasts, Competitive Strategies, Technology and Instrumentation Review, Opportunities for Suppliers

  • $ 5500
  • Industry report
  • October 2019

Global Respiratory Diseases: Adenovirus, Influenza, Legionella, Mononucleosis, Mycoplasma, Pneumonia, RSV, Tuberculosis--Country Shares, Market Segment Forecasts, Competitive Strategies, Technology and ...

  • Industries : Pathology, Medical Biotechnology, Healthcare
  • Countries : World, United States, Europe, Japan
Drug Delivery: Inhalation Devices

Drug Delivery: Inhalation Devices

  • $ 4750
  • Industry report
  • October 2019

OverviewIn 2018, combined sales of inhaled asthma and COPD devices in the countries covered by this analysis totaled approximately $10.4bn. Over the forecast period covered by this analysis, total sales ...

  • Industries : Drug Delivery, Chronic Disease, Pathology
  • Countries : United States, Japan
Global Market for Fracture Fixation Devices

Global Market for Fracture Fixation Devices

  • $ 4750
  • Industry report
  • August 2019

OverviewThis medical market and technology report provides a comprehensive discussion of the global market for fracture fixation devices. Geographic markets covered by this analysis include the US, Japan, ...

  • Industries : Health Services
  • Countries : United States, World, Japan
Global Hepatitis A, B, C, D, E Diagnostics Market: US, Europe, Japan--Supplier Shares and Strategies, Volum e and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review

Global Hepatitis A, B, C, D, E Diagnostics Market: US, Europe, Japan--Supplier Shares and Strategies, Volum e and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation Review

  • $ 4500
  • Industry report
  • October 2019

Global Hepatitis A, B, C, D, E Diagnostics Market: US, Europe, Japan--Supplier Shares and Strategies, Volum e and Sales Segment Forecasts for Immunodiagnostic and NAT Tests, Technology and Instrumentation ...

  • Industries : Pathology
  • Countries : United States, Europe, Japan, World
Prostate Cancer: Epidemiology Forecast to 2028

Prostate Cancer: Epidemiology Forecast to 2028

  • $ 3995
  • Industry report
  • August 2019

Prostate Cancer: Epidemiology Forecast to 2028SummaryProstate cancer is a malignancy in the prostate gland, which is located below the bladder and in front of the rectum in males. Worldwide, about 1.2 ...

  • Industries : Cancer, Pathology
  • Countries : United States, Japan

Reportlinker.com © Copyright 2019. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.

Make sure you don’t miss any news and follow us on